Henry I. Jacoby

2.1k total citations
42 papers, 1.7k citations indexed

About

Henry I. Jacoby is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Henry I. Jacoby has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Physiology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Henry I. Jacoby's work include Neuropeptides and Animal Physiology (13 papers), Pain Mechanisms and Treatments (9 papers) and Receptor Mechanisms and Signaling (7 papers). Henry I. Jacoby is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Pain Mechanisms and Treatments (9 papers) and Receptor Mechanisms and Signaling (7 papers). Henry I. Jacoby collaborates with scholars based in United States, Belgium and United Kingdom. Henry I. Jacoby's co-authors include David A. Brodie, Robert B. Raffa, Jeffry L. Vaught, Robert B. Raffa, Wolfgang Reimann, Elmar Friderichs, Richard P. Shank, E E Codd, Norma Selve and James J. Schupsky and has published in prestigious journals such as Nature, JAMA and Gastroenterology.

In The Last Decade

Henry I. Jacoby

41 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Henry I. Jacoby United States 20 471 447 404 403 267 42 1.7k
Pierre Rivière France 31 556 1.2× 731 1.6× 265 0.7× 695 1.7× 28 0.1× 76 2.1k
W. Krömer Germany 21 209 0.4× 611 1.4× 342 0.8× 481 1.2× 30 0.1× 72 1.4k
J. W. Black United Kingdom 13 577 1.2× 1.1k 2.6× 367 0.9× 468 1.2× 54 0.2× 36 2.6k
A. Walland Germany 14 231 0.5× 588 1.3× 120 0.3× 293 0.7× 64 0.2× 48 1.3k
Thomas Weiser Germany 26 325 0.7× 1.1k 2.5× 128 0.3× 476 1.2× 118 0.4× 76 2.3k
P. Donatsch Switzerland 19 257 0.5× 927 2.1× 401 1.0× 575 1.4× 24 0.1× 45 2.2k
Daniel L. Hogan United States 24 175 0.4× 450 1.0× 728 1.8× 128 0.3× 25 0.1× 62 1.6k
David T. Beattie United States 34 438 0.9× 1.1k 2.4× 589 1.5× 692 1.7× 10 0.0× 90 3.5k
P.L. Rayford United States 20 193 0.4× 536 1.2× 376 0.9× 419 1.0× 48 0.2× 59 2.7k
Charles Β. Clayman United States 12 126 0.3× 259 0.6× 316 0.8× 189 0.5× 26 0.1× 30 1.4k

Countries citing papers authored by Henry I. Jacoby

Since Specialization
Citations

This map shows the geographic impact of Henry I. Jacoby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry I. Jacoby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry I. Jacoby more than expected).

Fields of papers citing papers by Henry I. Jacoby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henry I. Jacoby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry I. Jacoby. The network helps show where Henry I. Jacoby may publish in the future.

Co-authorship network of co-authors of Henry I. Jacoby

This figure shows the co-authorship network connecting the top 25 collaborators of Henry I. Jacoby. A scholar is included among the top collaborators of Henry I. Jacoby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henry I. Jacoby. Henry I. Jacoby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koetzner, Lee, Gary J. Grover, Jamie Boulet, & Henry I. Jacoby. (2009). Plant-Derived Polysaccharide Supplements Inhibit Dextran Sulfate Sodium-Induced Colitis in the Rat. Digestive Diseases and Sciences. 55(5). 1278–1285. 28 indexed citations
2.
Jacoby, Henry I., et al.. (2001). The Effect of MGN-3 on Cisplatin and Doxorubicin Induced Toxicity in the Rat. 3(4). 3–11. 17 indexed citations
3.
Raffa, Robert B., James J. Schupsky, & Henry I. Jacoby. (1996). Endothelin-induced nociception in mice: mediation by ETA and ETB receptors.. Journal of Pharmacology and Experimental Therapeutics. 276(2). 647–651. 54 indexed citations
4.
Raffa, Robert B., Tamara Goode, Rebecca P. Martinez, & Henry I. Jacoby. (1995). A Gi2α antisense oligonucleotide differentiates morphine antinociception, constipation and acute dependence in mice. Life Sciences. 58(5). PL73–PL76. 16 indexed citations
5.
Jacoby, Henry I., et al.. (1993). Vasorelaxant effect of the potassium channel activator, RWJ 29009, is tissue selective. Life Sciences. 52(21). PL233–PL238. 2 indexed citations
6.
Raffa, Robert B. & Henry I. Jacoby. (1991). Endothelin-1, -2 and -3 directly and big-endothelin-1 indirectly elicit an abdominal constriction response in mice. Life Sciences. 48(17). PL85–PL90. 25 indexed citations
7.
Jacoby, Henry I., et al.. (1991). Central and peripheral administration of serotonin produces opposite effects on mouse colonic propulsive motility. Neuroscience Letters. 122(1). 122–126. 8 indexed citations
8.
9.
Raffa, Robert B. & Henry I. Jacoby. (1989). FMRFamide enhances acetylcholine-induced contractions of guinea pig ileum. Peptides. 10(3). 693–695. 15 indexed citations
10.
Jacoby, Henry I.. (1988). V. Gastrointestinal tachykinin receptors. Life Sciences. 43(26). 2203–2208. 9 indexed citations
11.
Jacoby, Henry I., et al.. (1987). The effect of Phe-Met-Arg-Phe-NH2 (FMRFamide) on morphine-induced inhibition of colonic propulsive motility in mice. Neuroscience Letters. 83(1-2). 128–132. 30 indexed citations
12.
Raffa, Robert B., Joanne R. Mathiasen, & Henry I. Jacoby. (1987). Colonic bead expulsion time in normal and μ-opioid receptor deficient (CXBK) mice following central (ICV) administration of μ- and δ-opioid agonists. Life Sciences. 41(19). 2229–2234. 57 indexed citations
13.
Murray, Christopher W., et al.. (1987). Neurokinin-induced salivation in the anesthetized rat: a three receptor hypothesis.. Journal of Pharmacology and Experimental Therapeutics. 242(2). 500–506. 17 indexed citations
14.
Vaught, Jeffry L., et al.. (1984). Tachykinin-like central activity of neuromedin K in mice. European Journal of Pharmacology. 103(3-4). 355–357. 30 indexed citations
15.
Jacoby, Henry I., et al.. (1984). Antisecretory activity of fenoctimine in rat and dog. Digestive Diseases and Sciences. 29(12). 1131–1136. 7 indexed citations
16.
Scott, Malcolm K., et al.. (1983). 4-(Diphenylmethyl)-1-(iminomethyl)piperidines as gastric antisecretory agents. Journal of Medicinal Chemistry. 26(4). 535–538. 21 indexed citations
17.
Hageman, William, et al.. (1980). Cardiovascular profile of mixidine fumarate, a compound which attenuates myocardial chronotropic responses.. Journal of Pharmacology and Experimental Therapeutics. 212(3). 514–518. 5 indexed citations
18.
Jacoby, Henry I., et al.. (1979). Antisecretory Actions of Aminophylline in the Rat and Dog. Digestion. 19(4). 237–243. 1 indexed citations
19.
Jacoby, Henry I., et al.. (1978). Possible Ion-Pair-Mediated Absorption of Mixidine I: Partitioning and Lethality Studies. Journal of Pharmaceutical Sciences. 67(7). 945–948. 7 indexed citations
20.
Jacoby, Henry I., et al.. (1969). Gastric Motor-Stimulating Activity of Gastrin Tetrapeptide in Dogs. Gastroenterology. 56(1). 80–87. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pierre Rivière Breakdown of academic impact, for papers by W. Krömer Breakdown of academic impact, for papers by J. W. Black Breakdown of academic impact, for papers by A. Walland Breakdown of academic impact, for papers by Thomas Weiser Breakdown of academic impact, for papers by P. Donatsch Breakdown of academic impact, for papers by Daniel L. Hogan Breakdown of academic impact, for papers by David T. Beattie Breakdown of academic impact, for papers by P.L. Rayford Breakdown of academic impact, for papers by Charles Β. Clayman
Rankless by CCL
2026